Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
Yahoo Finance
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
Needham analyst Ami Fadia raised the firm’s price target on Jazz Pharmaceuticals (JAZZ) to $235 from $210 and keeps a Buy rating on the shares. T...